Detection of Brain Metastasis by MRI in Metastatic Colorectal Cancer Patients
Not Applicable
Recruiting
- Conditions
- Metastatic Colon Cancer
- Interventions
- Device: Magnetic resonance imaging
- Registration Number
- NCT03694938
- Lead Sponsor
- Poitiers University Hospital
- Brief Summary
The aim of this study is to prospectively determine the incidence of brain metastases in metastatic colorectal cancer patients using systematic annual screening by MRI.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- Patients with histologically proven colorectal adenocarcinoma
- Metastases from colorectal cancer diagnosed since less than 6 months
- Indication of an oncologic treatment
Exclusion Criteria
- Patient with contraindication for MRI
- Diagnosis of cancer other than colorectal cancer in the last three years, except in situ cancers, basal-cell skin cancer or squamous-cell skin cancer, and other cancer with low risk of brain dissemination according to the investigator
- Pregnant or breastfeeding women, women of childbearing potential without effective contraception
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Magnetic resonance imaging Magnetic resonance imaging Annual MRI during 3 years
- Primary Outcome Measures
Name Time Method Prospectively determine the incidence of brain metastases in metastatic colorectal cancer patients with annual MRI. 3 years Diagnostic of brain metastases on annual MRI
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (4)
C.H.U. de Tours
🇫🇷Tours, France
C.H.U. d'Amiens
🇫🇷Amiens, France
C.H.U. de Poitiers
🇫🇷Poitiers, France
Hôpital Privé Jean Mermoz
🇫🇷Lyon, France